MoDEL™, QuarkBio’s Digital Liquid Biopsy Assay on DigiChip™, detects EGFR T790M drug-resistant mutation in patients with non-small cell lung adenocarcinoma for treatment guidance.
Digital qPCR Applications
User Story #2
Patients with Lung Cancer Due to Exon 19 mutation in EGFR
- Exon 19 deletion was detected from patient’s tissue using qPCR
- Deletion was confirmed using patients’ blood sample using MoDEL™
